Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Pharma Stock Roundup: Novo Nordisk's New Obesity Pill Data, Roche, AstraZeneca's Pipeline Updates
![](https://talkmarkets.com/user_content/contacts/thumb_974E840B-81A9-437A-8FC5-0A85B46C2A57.jpeg?app=196659)
Article By:
Zacks Investment Research
Saturday, March 9, 2024 1:40 PM EDT
This week, data from Novo Nordisk’s early-stage study on a new weight loss pill called amycretin showed that it could be more effective than Wegovy. Meanwhile, the FDA approved Johnson & Johnson's lung cancer medicine, Rybrevant, for first-line use.
Alnylam Launches “Alnylam P5x25” Strategy For Planned Transition To A Top Five Biotech In Market Capitalization Over Next Five Years
![](https://talkmarkets.com/user_content/contacts/thumb_EFAC7999-FFC1-434D-8653-3A2B4A2BDC2D.jpeg?app=197199)
Article By:
Business Wire
Sunday, January 10, 2021 3:08 PM EDT
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced its new five-year strategy, “Alnylam P5x25,” which is focused on the company’s transition to a top-5 biotech (measured by market capitalization) in the next five years.
In this article: ALNY
The Week Ahead In Biotech: Urogen FDA Decision, Amarin, J&J Earnings And More COVID-19 Updates
![](https://talkmarkets.com/user_content/contacts/thumb_BBA6AA2A-0CF1-44B6-9D5B-AC9723F61D4F.jpeg?app=283608)
Article By:
Benzinga
Sunday, April 12, 2020 1:22 PM EDT
Biotech stocks moved higher last week along with the broader market. The week witnessed a few clinical readouts and pre-announcements that reflected the coronavirus (COVID-19) impact.